{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:58:54Z","timestamp":1793897934604,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2020-06448"],"award-info":[{"award-number":["2020-06448"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2020-06448"],"award-info":[{"award-number":["2020-06448"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2020-06448"],"award-info":[{"award-number":["2020-06448"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI147109"],"award-info":[{"award-number":["R01AI147109"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI147109"],"award-info":[{"award-number":["R01AI147109"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI147109"],"award-info":[{"award-number":["R01AI147109"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01460-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:05:56Z","timestamp":1776762356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models"],"prefix":"10.1038","volume":"11","author":[{"given":"Joshua","family":"Wiggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adthakorn","family":"Madapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","first-page":"e0042425","DOI":"10.1128\/jvi.00424-25","volume":"99","author":"Z Xie","year":"2025","unstructured":"Xie, Z. et al. Clade 2.3.4.4b highly pathogenic avian influenza H5N1 viruses: knowns, unknowns, and challenges. J. Virol. 99, e0042425 (2025).","journal-title":"J. Virol."},{"key":"1460_CR2","doi-asserted-by":"publisher","unstructured":"Graziosi, G., Lupini, C., Catelli, E. & Carnaccini, S. Highly pathogenic avian influenza (HPAI) H5 clade 2.3.4.4b virus infection in birds and mammals. Animals 14 https:\/\/doi.org\/10.3390\/ani14091372 (2024).","DOI":"10.3390\/ani14091372"},{"key":"1460_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2270068","volume":"12","author":"IV Chestakova","year":"2023","unstructured":"Chestakova, I. V. et al. High number of HPAI H5 virus infections and antibodies in wild carnivores in the Netherlands, 2020-2022. Emerg. Microbes Infect. 12, 2270068 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1460_CR4","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3201\/eid2912.230464","volume":"29","author":"EJ Elsmo","year":"2023","unstructured":"Elsmo, E. J. et al. Highly pathogenic avian influenza A(H5N1) Virus Clade 2.3.4.4b infections in wild terrestrial mammals, United States, 2022. Emerg. Infect. Dis. 29, 2451\u20132460 (2023).","journal-title":"Emerg. Infect. Dis."},{"key":"1460_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","volume":"634","author":"LC Caserta","year":"2024","unstructured":"Caserta, L. C. et al. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 634, 669\u2013676 (2024).","journal-title":"Nature"},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41586-024-08166-6","volume":"637","author":"AL Baker","year":"2025","unstructured":"Baker, A. L. et al. Dairy cows inoculated with highly pathogenic avian influenza virus H5N1. Nature 637, 913\u2013920 (2025).","journal-title":"Nature"},{"key":"1460_CR7","unstructured":"USDA. HPAI Confirmed Cases in Livestock | Animal and Plant Health Inspection Service (USDA, 2025)."},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJMc2405495","volume":"391","author":"L Guan","year":"2024","unstructured":"Guan, L. et al. Cow\u2019s milk containing avian influenza A(H5N1) virus-heat inactivation and infectivity in mice. N. Engl. J. Med. 391, 87\u201390 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"e0213824","DOI":"10.1128\/jvi.02138-24","volume":"99","author":"Y Lang","year":"2025","unstructured":"Lang, Y. et al. Detection of antibodies against influenza A viruses in cattle. J. Virol. 99, e0213824 (2025).","journal-title":"J. Virol."},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41586-024-08063-y","volume":"637","author":"NJ Halwe","year":"2025","unstructured":"Halwe, N. J. et al. H5N1 clade 2.3.4.4b dynamics in experimentally infected calves and cows. Nature 637, 903\u2013912 (2025).","journal-title":"Nature"},{"key":"1460_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61553-z","volume":"16","author":"F Pena-Mosca","year":"2025","unstructured":"Pena-Mosca, F. et al. The impact of highly pathogenic avian influenza H5N1 virus infection on dairy cows. Nat. Commun. 16, 6520 (2025).","journal-title":"Nat. Commun."},{"key":"1460_CR12","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMc2405371","volume":"390","author":"TM Uyeki","year":"2024","unstructured":"Uyeki, T. M. et al. Highly pathogenic Avian Influenza A(H5N1) virus infection in a dairy farm worker. N. Engl. J. Med. 390, 2028\u20132029 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.15585\/mmwr.mm7321e1","volume":"73","author":"S Garg","year":"2024","unstructured":"Garg, S. et al. Outbreak of highly pathogenic avian influenza A(H5N1) viruses in U.S. dairy cattle and detection of two human cases-United States, 2024. MMWR Morb. Mortal. Wkly Rep. 73, 501\u2013505 (2024).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","volume":"633","author":"AJ Eisfeld","year":"2024","unstructured":"Eisfeld, A. J. et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature 633, 426\u2013432 (2024).","journal-title":"Nature"},{"key":"1460_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87831-w","volume":"15","author":"MS Abousenna","year":"2025","unstructured":"Abousenna, M. S., Shafik, N. G. & Abotaleb, M. M. Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine. Sci. Rep. 15, 4637 (2025).","journal-title":"Sci. Rep."},{"key":"1460_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01238-2","volume":"10","author":"N Paran","year":"2025","unstructured":"Paran, N. et al. Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle. NPJ Vaccines 10, 197 (2025).","journal-title":"NPJ Vaccines"},{"key":"1460_CR17","doi-asserted-by":"publisher","unstructured":"Souza, C. K. et al. H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves. bioRxiv, Preprint at https:\/\/doi.org\/10.1101\/2025.05.01.651548 (2025).","DOI":"10.1101\/2025.05.01.651548"},{"key":"1460_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00503-y","volume":"7","author":"T Travieso","year":"2022","unstructured":"Travieso, T., Li, J., Mahesh, S., Mello, J. & Blasi, M. The use of viral vectors in vaccine development. NPJ Vaccines 7, 75 (2022).","journal-title":"NPJ Vaccines"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"1535328","DOI":"10.3389\/fvets.2025.1535328","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang, J., Cui, J., Li, G. & Yu, L. Research advances in replication-deficient viral vector vaccines. Front. Vet. Sci. 12, 1535328 (2025).","journal-title":"Front. Vet. Sci."},{"key":"1460_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.4161\/hv.27238","volume":"10","author":"EA Weaver","year":"2014","unstructured":"Weaver, E. A. Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors. Hum. Vaccin. Immunother. 10, 544\u2013556 (2014).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"e0241320","DOI":"10.1128\/JVI.02413-20","volume":"95","author":"N Lejeune","year":"2021","unstructured":"Lejeune, N. et al. Infection of bronchial epithelial cells by the human adenoviruses A12, B3, and C2 differently regulates the innate antiviral effector APOBEC3B. J. Virol. 95, e0241320 (2021).","journal-title":"J. Virol."},{"key":"1460_CR22","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1128\/JVI.74.20.9617-9628.2000","volume":"74","author":"AE Morelli","year":"2000","unstructured":"Morelli, A. E. et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J. Virol. 74, 9617\u20139628 (2000).","journal-title":"J. Virol."},{"key":"1460_CR23","doi-asserted-by":"publisher","first-page":"e0140702","DOI":"10.1371\/journal.pone.0140702","volume":"10","author":"RJ Webby","year":"2015","unstructured":"Webby, R. J. & Weaver, E. A. Centralized consensus hemagglutinin genes induce protective immunity against H1, H3 and H5 influenza viruses. PLoS One 10, e0140702 (2015).","journal-title":"PLoS One"},{"key":"1460_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14891-y","volume":"7","author":"A Lingel","year":"2017","unstructured":"Lingel, A., Bullard, B. L. & Weaver, E. A. Efficacy of an adenoviral vectored multivalent centralized influenza vaccine. Sci. Rep. 7, 14912 (2017).","journal-title":"Sci. Rep."},{"key":"1460_CR25","doi-asserted-by":"publisher","unstructured":"Madapong, A., Wiggins, J., DeBeauchamp, J., Webby, R. J. & Weaver, E. A. Systemic and mucosal immune responses induced by adenoviral-vectored consensus H5 influenza a vaccines in mice and swine. Vaccines 13 https:\/\/doi.org\/10.3390\/vaccines13090928 (2025).","DOI":"10.3390\/vaccines13090928"},{"key":"1460_CR26","doi-asserted-by":"publisher","unstructured":"Sreenivasan, C. C., Thomas, M., Kaushik, R. S., Wang, D. & Li, F. Influenza A in bovine species: a narrative literature review. Viruses 11, https:\/\/doi.org\/10.3390\/v11060561 (2019).","DOI":"10.3390\/v11060561"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/21645515.2015.1016674","volume":"11","author":"K Xiang","year":"2015","unstructured":"Xiang, K. et al. Progress on adenovirus-vectored universal influenza vaccines. Hum. Vaccin. Immunother. 11, 1209\u20131222 (2015).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"102594","DOI":"10.1016\/j.omtn.2025.102594","volume":"36","author":"WC Wang","year":"2025","unstructured":"Wang, W. C. et al. A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets. Mol. Ther. Nucleic Acids 36, 102594 (2025).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1460_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/viro.2000.0661","volume":"278","author":"MK Baxi","year":"2000","unstructured":"Baxi, M. K. et al. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats. Virology 278, 234\u2013243 (2000).","journal-title":"Virology"},{"key":"1460_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0264-410X(01)00458-3","volume":"20","author":"S Gogev","year":"2002","unstructured":"Gogev, S. et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine 20, 1451\u20131465 (2002).","journal-title":"Vaccine"},{"key":"1460_CR31","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1128\/JVI.00979-13","volume":"87","author":"CW Seibert","year":"2013","unstructured":"Seibert, C. W. et al. Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs. J. Virol. 87, 7793\u20137804 (2013).","journal-title":"J. Virol."},{"key":"1460_CR32","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","volume":"173","author":"KB Renegar","year":"2004","unstructured":"Renegar, K. B., Small, P. A. Jr., Boykins, L. G. & Wright, P. F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173, 1978\u20131986 (2004).","journal-title":"J. Immunol."},{"key":"1460_CR33","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","volume":"168","author":"Y Asahi","year":"2002","unstructured":"Asahi, Y. et al. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168, 2930\u20132938 (2002).","journal-title":"J. Immunol."},{"key":"1460_CR34","doi-asserted-by":"publisher","unstructured":"Bullard, B. L. & Weaver, E. A. Strategies targeting hemagglutinin as a universal influenza vaccine. Vaccines 9 https:\/\/doi.org\/10.3390\/vaccines9030257 (2021).","DOI":"10.3390\/vaccines9030257"},{"key":"1460_CR35","doi-asserted-by":"publisher","first-page":"e73313","DOI":"10.1371\/journal.pone.0073313","volume":"8","author":"EA Weaver","year":"2013","unstructured":"Weaver, E. A. & Barry, M. A. Low seroprevalent species D adenovirus vectors as influenza vaccines. PloS One 8, e73313 (2013).","journal-title":"PloS One"},{"key":"1460_CR36","doi-asserted-by":"publisher","first-page":"e67574","DOI":"10.1371\/journal.pone.0067574","volume":"8","author":"EA Weaver","year":"2013","unstructured":"Weaver, E. A. et al. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One 8, e67574 (2013).","journal-title":"PLoS One"},{"key":"1460_CR37","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","volume":"172","author":"DH Barouch","year":"2004","unstructured":"Barouch, D. H. et al. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J. Immunol. 172, 6290\u20136297 (2004).","journal-title":"J. Immunol."},{"key":"1460_CR38","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. 70, 767\u2013777 (1972).","journal-title":"J. Hyg."},{"key":"1460_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2014.03.008","volume":"29","author":"K Haq","year":"2014","unstructured":"Haq, K. & McElhaney, J. E. Immunosenescence: influenza vaccination and the elderly. Curr. Opin. Immunol. 29, 38\u201342 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"1460_CR40","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","volume":"30","author":"S Black","year":"2011","unstructured":"Black, S. et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr. Infect. Dis. J. 30, 1081\u20131085 (2011).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"1460_CR41","doi-asserted-by":"publisher","unstructured":"Sun, Y. et al. Effect of inoculation volume on a mouse model of influenza virus infected with the same viral load. Vaccines 13 https:\/\/doi.org\/10.3390\/vaccines13020173 (2025).","DOI":"10.3390\/vaccines13020173"},{"key":"1460_CR42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12985-024-02516-6","volume":"21","author":"XY Jin","year":"2024","unstructured":"Jin, X. Y. et al. Comparative pathogenicity of influenza virus-induced pneumonia mouse model following intranasal and aerosolized intratracheal inoculation. Virol. J. 21, 240 (2024).","journal-title":"Virol. J."},{"key":"1460_CR43","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","volume":"172","author":"A Jegerlehner","year":"2004","unstructured":"Jegerlehner, A., Schmitz, N., Storni, T. & Bachmann, M. F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol. 172, 5598\u20135605 (2004).","journal-title":"J. Immunol."},{"key":"1460_CR44","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","volume":"148","author":"G Hashimoto","year":"1983","unstructured":"Hashimoto, G., Wright, P. F. & Karzon, D. T. Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J. Infect. Dis. 148, 785\u2013794 (1983).","journal-title":"J. Infect. Dis."},{"key":"1460_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coviro.2016.12.002","volume":"22","author":"HA Vanderven","year":"2017","unstructured":"Vanderven, H. A., Jegaskanda, S., Wheatley, A. K. & Kent, S. J. Antibody-dependent cellular cytotoxicity and influenza virus. Curr. Opin. Virol. 22, 89\u201396 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"1460_CR46","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1073\/pnas.100133697","volume":"97","author":"E Hoffmann","year":"2000","unstructured":"Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. USA 97, 6108\u20136113 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1460_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.118.2.295","volume":"118","author":"WC Wilcox","year":"1963","unstructured":"Wilcox, W. C. & Ginsberg, H. S. Structure of type 5 adenovirus. I. Antigenic relationship of virus-structural proteins to virus-specific soluble antigens from infected cells. J. Exp. Med. 118, 295\u2013306 (1963).","journal-title":"J. Exp. Med."},{"key":"1460_CR48","doi-asserted-by":"publisher","unstructured":"Pekarek, M. J., Madapong, A., Wiggins, J. & Weaver, E. A. Adenoviral-Vectored Multivalent Vaccine Provides Durable Protection Against Influenza B Viruses from Victoria-like and Yamagata-like Lineages. Int. J. Mol. Sci. 26 https:\/\/doi.org\/10.3390\/ijms26041538 (2025).","DOI":"10.3390\/ijms26041538"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01460-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01460-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01460-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T23:08:36Z","timestamp":1782083316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01460-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01460-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.09.21.677614","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}